Results 111 to 120 of about 106,775 (245)

Obesity Treatments to Improve Type 1 Diabetes (OTID): a randomized controlled trial of the combination of glucagon-like peptide 1 analogues and sodium-glucose cotransporter 2 inhibitors—protocol for Obesity Treatments to Improve Type 1 Diabetes (the OTID trial)

Trials
Background The guidelines of the American Diabetes Association and European Association for the Study of Diabetes suggest that patients with obesity type 2 diabetics and chronic kidney disease need either glucagon-like peptide 1 receptor analogues or ...
Ebaa Al-Ozairi, Kavita Narula, Alexander D. Miras, Etab Taghadom, Abeer El Samad, Jumana Al Kandari, Anas Alyosef, Anant Mashankar, Werd Al-Najim, Carel W. le Roux   +9 more
doaj   +1 more source

Inhibitory and excitatory enteric neurons of the mouse duodenum co-express the Glucagon-like Peptide 1 or Glucagon-like Peptide 2 receptors

, 2010
Maria Giuliana Vannucchi, Lorenzo Cinci, Maria Simonetta Faussone‐Pellegrini   +2 more
openalex   +1 more source

Functional Consequences of Glucagon-like Peptide-1 Receptor Cross-talk and Trafficking [PDF]

, 2014
Sarah Noerklit Roed, Anne Cathrine Nøhr, Pernille Wismann, Helle K. Iversen, Hans Bräuner‐Osborne, Sanne Moeller Knudsen, Maria Waldhoer   +6 more
openalex   +1 more source

The effectiveness of the glucagon‐like peptide 1 receptor agonist in improving cognitive function [PDF]

, 2023
Naoise Rasmussen, Richéal Burns, Karen Coughlan   +2 more
openalex   +1 more source

Glucagon-like peptide-1 receptors in the brain: controlling food intake and body weight [PDF]

, 2014
Laurie L. Baggio, Daniel J. Drucker
openalex   +1 more source

Impact of a Weekly Glucagon-Like Peptide 1 Receptor Agonist, Albiglutide, on Glycemic Control and on Reducing Prandial Insulin Use in Type 2 Diabetes Inadequately Controlled on Multiple Insulin Therapy: A Randomized Trial [PDF]

, 2020
Julio Rosenstock, Antonio Nino, Joseph Soffer, Lois Erskine, Andre Acusta, Jo Dole, Molly C. Carr, Jason L. Mallory, Philip Home   +8 more
openalex   +1 more source

Perioperative management of long-acting glucagon-like peptide-1 (GLP-1) receptor agonists. Comment on Br J Anaesth 2024; 132: 644–8 [PDF]

Paul Potnuru, Nadia Hernandez, Omonele O. Nwokolo, Sudipta Sen   +3 more
openalex   +1 more source

The glucagon-like peptide-1 receptor agonist exenatide restores impaired pro-islet amyloid polypeptide processing in cultured human islets: implications in type 2 diabetes and islet transplantation [PDF]

, 2012
Y. J. Park, Z. Ao, Timothy J. Kieffer, H. Chen, Nooshin Safikhan, David Thompson, Mark Meloche, Garth L. Warnock, Lucy Marzban   +8 more
openalex   +1 more source

Novel Compounds as Glucagon-Like Peptide‑1 Receptor Agonists for Treating Diabetes. [PDF]

ACS Med Chem Lett
Sabnis RW.
europepmc   +1 more source

Incretin Receptors for Glucagon-Like Peptide 1 and Glucose-Dependent Insulinotropic Polypeptide Are Essential for the Sustained Metabolic Actions of Vildagliptin in Mice [PDF]

, 2007
Grace Flock, Laurie L. Baggio, Christine Longuet, Daniel J. Drucker   +3 more
openalex   +1 more source